Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
TherapeuticsMD, an innovative, leading women’s healthcare company, today announced that it has entered into definitive […]
Telix Announces Executive Leadership Appointments
Telix Pharmaceuticals has announced several key executive leadership appointments and promotions, reflecting the increased commercial […]
Syndax Pharmaceuticals Announces Appointment of Steve Sabus as Chief Commercial Officer
Syndax Pharmaceuticals, a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, has announced […]
Inszone Insurance Services Completes Acquisition of Kirsch Insurance Group
Inszone Insurance Services, a rapidly growing, national provider of benefits, personal and commercial lines insurance, […]
Nemysis and Faran S.A. Sign Agreement to Cooperate for the Development of Endopeptidase E40 for Celiac Disease
Nemysis Ltd has announced a Strategic Cooperation with Faran S.A., a leading Greek pharma company, […]
Focus-X Therapeutics Successfully Reached an Acquisition Agreement with Full-Life Technologies
Focus-X Therapeutics, a nuclide drug company that was invested in and incubated by Viva Biotech, […]
Rocket Pharmaceuticals Completes Acquisition of Renovacor
Rocket Pharmaceuticals, a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic […]
AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy
AstraZeneca has announced an agreement to acquire Neogene Therapeutics, a global clinical-stage biotechnology company pioneering […]
Colleen Flesher Appointed Co-CEO for Movora
Colleen Flesher, currently COO Movora, has been appointed new Co-CEO of veterinary MedTech leader Movora, […]
SpectrumX’s Hand Sanitiser Approved for NHS Supply Chain’s NHS Supplier List
SpectrumX, a UK-based healthcare and pharmaceutical company, has announced that it has officially been informed, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more